Investor meet intimation
Awaiting price reaction for this filing.
Eris Lifesciences has informed the stock exchanges about a scheduled meeting with institutional investors. The company will meet with NT Asset Management on Tuesday, June 24, 2025, in a virtual format. This is part of the company's regular investor engagement activities. Importantly, the company has clarified that only publicly available documents will be discussed and no unpublished price sensitive information (UPSI) will be shared. The filing was made under SEBI's Listing Obligations and Disclosure Requirements Regulations, 2015.
This is a routine compliance filing with no material impact on the stock price. It reflects normal investor outreach activity and confirms the company is engaging with institutional investors, which is generally positive for visibility but not a near-term catalyst.